Log In
BCIQ
Print this Print this
 

HL063B

  Manage Alerts
Collapse Summary General Information
Company HanAll Biopharma Co. Ltd.
DescriptionFixed dose combination of telmisartan and chlorthalidone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase III
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today